Viruses as weapons, academic laundering of intelligence, and the 2026 hantavirus outbreak as live case study

alimcforever.substack.com | 6 May 2026

---

There is a hantavirus outbreak on a cruise ship right now. Three people are dead. Eight confirmed or suspected cases. The ship is anchored off Cape Verde. Nobody has released the full genome data.

What is happening on the ship

The vessel: MV Hondius. Dutch-flagged expedition cruise ship. Operated by Oceanwide Expeditions, based in the Netherlands.

The voyage: Departed Ushuaia, Argentina, 1 April 2026. Carried 147 people — 88 passengers, 59 crew, from 23 countries. Route: Antarctica, South Georgia, Nightingale Island, Tristan da Cunha, Saint Helena, Ascension Island, heading north toward Cape Verde.[^1]

The timeline, by primary source:

• 6 April: First passenger becomes ill. A Dutch national. Fever.

• 11 April: That passenger dies on board. Cause unknown at this point.

• 24 April: Body disembarked at Saint Helena. His wife travels with the body.

• 25 April: Wife falls ill during the flight to Johannesburg.

• 26 April: Wife dies on arrival at the emergency department in Johannesburg.

• 27 April: A British passenger, ill since 24 April, is medically evacuated from Ascension Island to South Africa.

• 28 April: Last illness onset reported on the ship.

• 2 May: The British patient tests positive for hantavirus by PCR, after a full respiratory pathogen panel comes back negative. Dr Lucille Blumberg at South Africa's National Institute for Communicable Diseases (NICD) confirms it. WHO is notified the same day.

• 3 May: A third death on board, reported as a German national. WHO publishes Disease Outbreak Notice DON599. RFK Jr posts a photograph of himself holding a starling at Dulles Airport. He is the US Secretary of Health and Human Services.

• 4 May: WHO confirms 7 cases (2 lab-confirmed, 5 suspected), 3 deaths. ECDC publishes a statement classifying risk to Europe as "very low."

• 5 May: BBC reports South African health authorities have identified the strain as Andes virus in both confirmed cases.

• 6 May: An eighth case identified. Three more patients evacuated to the Netherlands. British patient no longer critical. Full genome sequence not yet publicly available.

The primary sources for this section are: WHO DON599 (https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599), the Oceanwide Expeditions timeline (https://oceanwide-expeditions.com/blog/press-update-timeline-of-the-medical-situation-on-board-the-m-v-hondius), and Science magazine's 2 May briefing.

What Andes virus actually is

Most hantaviruses infect humans through contact with infected rodent urine, droppings, or saliva. Usually by inhaling particles. You don't catch hantavirus from another person. That is the standard textbook rule.[^10]

Andes virus is the only hantavirus in the world that breaks this rule.

The evidence for person-to-person transmission of Andes virus is not a rumour or a speculation. It is in a peer-reviewed paper in the CDC's own journal, Emerging Infectious Diseases, published in April 2020. The paper: Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Emerging Infectious Diseases, April 2020. Full text: https://wwwnc.cdc.gov/eid/article/26/4/19-0799_article[^11]

The case in that paper: a hospitalised patient had Andes virus. A nurse who cared for him developed symptoms. The researchers sequenced the virus from both patients. The sequences matched at 100% nucleotide identity. The nurse's only documented exposure was that clinical contact. Person-to-person transmission — confirmed by genome sequencing.[^11]

Andes virus kills 35–50% of the people it infects. It kills primarily healthy working-age adults — not the elderly, not the immunocompromised. This is the opposite pattern from most respiratory infections, which kill at the extremes of age and immune status.[^10]

There is no approved vaccine. There is no approved antiviral treatment.[^10]

It circulates in rodents in southern Argentina — the same region this ship departed from. The largest recent documented outbreak: Epuyén, Chubut Province, Argentina, 2018–19. One super-spreader event — a single party. 34 confirmed cases, 11 deaths, 142 contacts quarantined. Source: WHO Disease Outbreak Notice, 23 January 2019: https://www.who.int/emergencies/disease-outbreak-news/item/23-January-2019-hantavirus-argentina-en[^12]

How states conceal biological weapons programmes

Before mapping what the science actually shows, you need to understand the institutional context in which that science operates.

The United States programme, 1943–1969

The US ran an offensive biological weapons programme from spring 1943 until President Nixon terminated it by executive order in November 1969. This is documented. The National Security Archive holds the declassified records at: https://nsarchive2.gwu.edu/NSAEBB/NSAEBB58/[^13]

Over 27 years, the programme weaponised seven biological agents: anthrax, tularemia, brucellosis, Q-fever, Venezuelan equine encephalitis virus, botulinum toxin, and staphylococcal enterotoxin B. It also conducted field tests using simulants on non-consenting civilians. These are not allegations. These are in the government's own declassified historical record, available from the National Academy of Sciences: https://www.ncbi.nlm.nih.gov/books/NBK233494/

Nixon's November 1969 statement renouncing biological weapons — a primary source — is archived by the State Department: https://2001-2009.state.gov/r/pa/ho/frus/nixon/e2/83597.htm

The Soviet programme they hid for thirty years

On 2 April 1979, anthrax spores escaped from Military Compound 19 in Sverdlovsk, USSR — a biological weapons facility. At least 68 people died, all downwind of the facility. Soviet officials told the world it was contaminated meat. They removed all medical records. They maintained that cover story for twelve years.[^17][^18][^19][^20]

The outbreak's true cause was not confirmed until 1992, when a team led by Matthew Meselson of Harvard conducted an independent investigation after the Soviet Union collapsed. Their findings were published in Science, 18 November 1994: the victims' homes and workplaces were all located along a narrow zone extending south from the weapons facility, consistent with an aerosol release, not a food source.[^21]

Primary archive: the National Security Archive's Sverdlovsk documents: https://nsarchive2.gwu.edu/NSAEBB/NSAEBB61/

What this demonstrates: a state can operate a large-scale biological weapons programme while simultaneously being a signatory to international law banning it, sustain a cover story through a major accident and mass death, and have that cover story accepted internationally for over a decade.

The verification protocol that was killed

The 1972 Biological Weapons Convention bans the development, production, and stockpiling of biological weapons. 143 nations ratified it. It has no enforcement mechanism and no inspection regime.[^22]

After six years of negotiation, a verification protocol was drafted — mandatory declarations, on-site inspections, an oversight body. In July 2001, the United States withdrew from negotiations. John Bolton, then Under-Secretary of State for Arms Control, declared the protocol "dead, and is not going to be resurrected." Source: Issues in Science and Technology, 2002: https://issues.org/tucker/

The stated reason: the Pentagon objected to inspections of US biodefence installations. An interagency team had identified 38 problems with the protocol. Primary source: the BMJ, June 2001: https://pmc.ncbi.nlm.nih.gov/articles/PMC1173329/

The result: there is still no verification mechanism. No country's biological research facilities are subject to international inspection. Any state can run any biological programme it chooses, inside facilities it labels "biodefence."

How peer-reviewed papers can carry weapons information

This section documents a specific pattern: dual-use research — science with both legitimate defensive value and clear offensive application — repeatedly published in full in top-tier journals, with the weapons-relevant information intact.

Each case below is a real paper with a real URL.

Mousepox and immune system suppression, 2001

In February 2001, Australian researchers published a paper describing how they had accidentally created a mousepox virus lethal even to vaccinated mice. They had inserted the gene for interleukin-4 (IL-4) — a molecule that regulates immune responses — into the virus. Instead of acting as a contraceptive vaccine vehicle as intended, the modified virus suppressed the animals' cellular immunity entirely and killed all infected animals within nine days, including vaccinated ones.[^25]

The paper was published in the Journal of Virology: https://journals.asm.org/doi/10.1128/jvi.75.3.1205-1210.2001

Ken Alibek, former second-in-command of the Soviet civilian biological weapons programme, commented publicly: "It's a good way to show how to alter smallpox to make it more virulent."

US virologist Mark Buller then built on this work and produced a mousepox strain so lethal it killed all infected mice, even those that had been both vaccinated and treated with antiviral drugs. [^28]

The 1918 flu was rebuilt in a laboratory, 2005

The influenza pandemic of 1918–19 killed between 20 and 50 million people. In July 2005, CDC microbiologist Terrence Tumpey reconstructed the complete live 1918 virus in a secure laboratory, using reverse genetics. The work was approved by NIAID and the CDC director. The paper was published in Science in October 2005.

CDC's own account of this is in their archive

The virus that killed 50 million people was rebuilt. In a government laboratory. With published methodology.

H5N1 bird flu made airborne between mammals, 2011–12

In 2011, two independent research teams — Ron Fouchier at Erasmus Medical Center in Rotterdam, and Yoshihiro Kawaoka at the University of Wisconsin — each created mutant strains of H5N1 avian influenza capable of airborne transmission between ferrets. H5N1 kills approximately 60% of the humans it infects but does not naturally spread between people. Both teams demonstrated the mutations required to make it transmissible by respiratory droplet.

Both papers were funded by the US government.[^33]

The US National Science Advisory Board for Biosecurity initially recommended suppressing the key experimental details. In March 2012, it reversed that decision. Both papers were published in full.

Fouchier's paper in full: https://pmc.ncbi.nlm.nih.gov/articles/PMC4810786/[^32]

Kawaoka's paper in Nature: https://www.nature.com/articles/nature10831[^35]

These papers map the exact mutations needed to convert a bird virus into a mammal-transmissible strain. That information is publicly available.

The Andes virus biodefence paper, 2020

In August 2020, a paper was published in Frontiers in Bioengineering and Biotechnology: Biodefense Implications of New-World Hantaviruses. [^10]

The paper contains the following, explicitly:

• NIAID classifies hantaviruses as Category A — highest-priority bioterrorism threat. The CDC classifies them as Category C — pathogens that "could be engineered for mass dissemination due to availability, ease of production, and potential for high mortality."

• Andes virus uniquely combines person-to-person transmissibility, 35–50% lethality in healthy adults, no approved vaccine, no approved treatment.

• The paper maps the operational constraints on weaponisation: BSL-3 containment required, rodent delivery systems complex, environmental fragility in heat and UV light, difficulty of large-scale aerosolisation.

• The paper maps the targeting value: healthy working-age adults in agriculture, transport, shipping, and military settings.

• The paper then states: "there are no known major weapon development programs occurring."

"No known" is not the same as "none." The Soviet programme was also "not known" for thirty years. The disclaimer is a standard closing line. Its function is to allow the rest of the analysis to remain published without the paper being formally classified.

The capability stack built by public science

The biodefence paper does not appear from nowhere. It documents a body of work that took two decades to build. Below is the research infrastructure, in order.

2001: First peer-reviewed confirmation of Andes virus person-to-person transmission. A healthcare worker infected through patient contact. [^11]

2002: First human isolate of Andes virus recovered and cultured from an asymptomatic carrier, through three Vero E6 cell passages in a BSL-3 facility. [^36]

This matters because: you cannot experiment with a virus at scale without a stable culture. This paper confirmed Andes virus could be isolated and grown in laboratory cells.

2007: The United States Army Medical Research Institute of Infectious Diseases — USAMRIID — publishes a study on Andes virus and Sin Nombre virus infections in Syrian hamsters. This established lethality parameters and viral kinetics in a standard animal model. [^37]

USAMRIID is the US Army's primary biological defence research facility. It is located at Fort Detrick, Maryland — the same installation that ran the US offensive bioweapons programme before 1969. Its presence in the Andes virus literature is documented and attributed.

2012: The Public Health Agency of Canada and NIAID's Rocky Mountain Laboratories publish the first minigenome system for Andes virus. A minigenome system extracts and mimics parts of a virus's genome so you can study them in lower biosafety level conditions. It is the molecular foundation needed before you can manipulate the virus's genetics directly. [^38]

2023: A paper in Emerging Infectious Diseases maps the specific mutations in Andes virus that are associated with increased virulence in hamster models — directly connecting genome changes to disease outcomes. [^39]

2025: A paper published in PLOS Pathogens examines the genomic stability of Andes virus following successive passage experiments in hamsters. It finds that the virus remains stable across passages, which is necessary information for both vaccine development and — in a different frame — for understanding how the virus would behave during serial transmission between hosts. [^40]

February 2026: Two months before the MV Hondius departed Ushuaia, a paper was published mapping the molecular structure of the Andes virus entry protein — the part of the virus that allows it to attach to and enter human cells — at near-atomic resolution. [^41]

This sequence — isolation, culture, animal models, minigenome system, passage experiments, mutation mapping, entry protein structure — is the complete technical capability stack. It is documented. It is attributed. It is in the public record. Any institution with BSL-3 laboratory access and this literature could, in principle, work with live Andes virus.

---

The US-Ukraine laboratory programme

The Defence Threat Reduction Agency (DTRA) operates the Biological Threat Reduction Programme (BTRP) in Ukraine under an agreement signed in August 2005. This expanded the Nunn-Lugar Cooperative Threat Reduction programme, which was originally designed to secure Soviet-era weapons of mass destruction after 1991.[^42][^43]

The Pentagon's own fact sheet, published 10 March 2022, states: BTRP has supported 46 laboratories, facilities and diagnostic sites in Ukraine. Since 2005, the programme assisted in converting former Soviet biological weapons research facilities to support detection and diagnostic capabilities. [^44]

The DTRA Ukraine fact sheet states that the programme sponsored no gain-of-function research and no human experimentation. The Arms Control Association, reporting in 2005 as the agreement was signed, noted that among the Ukrainian facilities intended to receive upgrades were those formerly part of the Soviet-era anti-plague network — facilities that "continue to store libraries of naturally occurring pathogens." [^43]

What this establishes: the US government has direct institutional relationships with former Soviet biological research infrastructure, through a programme that includes pathogen security, outbreak detection, and diagnostic capability. The programme's stated purpose is peaceful. The same infrastructure — former bioweapons facilities converted to diagnostic labs — exists and is funded by the Pentagon.

What COVID demonstrated about how the money moves

The following numbers are from primary institutional sources. None are contested.

The extraction event in March 2020

On 18 March 2020, hedge fund manager Bill Ackman appeared on CNBC, told the anchor "hell is coming," and urged the US government to shut down the entire economy for thirty days to contain COVID-19. The interview moved markets. The S&P 500 fell.[^45]

Ackman had spent approximately $27 million on credit default swaps — financial instruments that pay out when corporate debt collapses — before going on television. He exited those positions on 23 March 2020. His return: $2.6 billion. A 9,500% return in 30 days. This is documented in his own firm's public statements. [^46][^45]

Ackman was not alone. Bloomberg reported short sellers made $51.3 billion in mark-to-market profits in the seven trading days following 24 February 2020. The headline: "Short Sellers Made Over $50 Billion During Coronavirus Sell-Off." [^47]

What happened to everyone else

While short sellers extracted $51 billion in seven days, 1.2 million jobs were permanently destroyed in the second quarter of 2020 alone.[^48]

UK small businesses lost £126.6 billion. [^49]

Global ecommerce revenue grew 19% in 2020 and a further 22% in 2021 — accelerating the consolidation of digital retail at the direct expense of physical independent businesses. [^50]

The vaccine contract structure

The US government signed its first advance purchase agreement with Pfizer-BioNTech on 21 July 2020: $1.95 billion for 100 million doses, with an option for up to 500 million additional doses. This was before any clinical trial results. The agreement was guaranteed regardless of regulatory outcome. [^51]

A retrospective study in the BMJ, published February 2023, calculated the total US public investment in mRNA COVID-19 vaccines at $31.9 billion, of which $29.2 billion (92%) was spent on purchasing doses — not on the research itself. The companies received guaranteed revenue before the vaccines were approved. [^52]

European advance purchase agreements: the EU signed contracts worth at least €93 billion on COVID-19 vaccines on behalf of member states. The contracts were signed behind closed doors. Leaked unredacted versions showed Pfizer received €700 million in advance payments, AstraZeneca €336 million, Moderna €318 million — before a single dose was administered. [^53]

Total vaccine profits: Pfizer, BioNTech, Moderna, and Sinovac made $90 billion in combined profits on COVID-19 vaccines in 2021 and 2022. [^54]

The billionaire wealth transfer

Combined billionaire wealth globally rose from approximately $8 trillion in March 2020 to over $13 trillion by early 2021 — a 68% increase during a period of mass unemployment, business closures, and 535,000 American deaths. [^55]

Oxfam reported that the ten richest men in the world doubled their fortunes during the pandemic — from $700 billion to $1.5 trillion — while the incomes of 99% of humanity fell. A new billionaire was created every 26 hours. [^56]

Amazon's net sales rose from $280 billion in 2019 to $386 billion in 2020 — a 38% increase in one year — as lockdowns closed competitors and shifted consumption online. [^57]

A peer-reviewed study in Health Economics documented a pattern the authors called "excess profits" — companies operating digitally exploited the lockdown-forced closure of physical competitors to capture permanent market share. [^58]

Naomi Klein documented this mechanism — crisis as cover for permanent structural transfer of wealth — twenty years ago in The Shock Doctrine (2007). The framework: a population-disrupting shock creates disorientation, disorientation suspends resistance, and structural changes that would normally be blocked happen in the window before people regroup. Klein applied it to Chile, Iraq, New Orleans. COVID applied it at global scale.

Applying the frame to the MV Hondius

No one has claimed responsibility for this outbreak. No sequencing data is public. but there are unignorable structural features to the outbreak that would also be consistent with a deliberate transmission study.

Closed population: 147 people on a ship. Defined exposure universe. Every contact traceable. This is the ideal study design for measuring secondary transmission rates in real conditions — far cleaner than community outbreaks where you cannot track every exposure.[^1]

Natural cover: The ship departed Ushuaia, Argentina. Andes virus circulates naturally in rodents in southern Argentina. Any cluster of cases on a ship that visited that region has a built-in plausible natural explanation that will be investigated first, slowing the timeline to alternative hypotheses.[^10][^12]

Transmission data: The precise information that does not yet exist in the public literature is the rate of person-to-person transmission of Andes virus in real-world conditions, at scale, outside a household or healthcare setting. The MV Hondius outbreak is generating exactly that data.[^11][^1]

Sequencing delay: As of 6 May 2026, the full genome is not publicly available. Full sequencing would reveal whether the virus is a known wild-type strain or carries unusual mutations. The absence of published sequence data is the central evidentiary gap.[^8][^9]

Institutional reassurance pace: WHO, ECDC, and national health agencies have all issued statements classifying risk as "very low" or contained, before sequencing is complete, before epidemiological reconstruction is finished, and before passenger exposure histories have been publicly documented.[^6][^1]

What the evidence requires now

1. Full genome release: The Andes virus sequences from all confirmed cases must be deposited in GenBank immediately and made publicly accessible. This is standard practice for outbreak investigation. The delay has no legitimate explanation if the goal is transparent public health response.

2. Independent epidemiological reconstruction: WHO's own investigation process must include independent epidemiologists — not only those working through national health agencies with institutional incentives to minimise. The 2020 Andes person-to-person transmission paper required full genome matching to confirm.

3. Passenger manifest cross-reference: The professional affiliations of all 147 people on board — not their identities, but their sectors — need to be part of the epidemiological investigation. Whether any passengers were affiliated with pharmaceutical, biodefence, or research institutions is relevant to establishing whether the ship was selected as a setting.

4. BWC Article V consultation: Under Article V of the Biological Weapons Convention, any state party that suspects another of violating the treaty can submit a formal complaint to the UN Security Council. No state has done this yet. Given the Andes virus capability stack documented above and the absence of genome data, a formal consultation would be proportionate.

5. Sequence comparison to published literature: When the genome is released, it needs to be compared against the 2023 and 2025 passage-experiment papers that mapped specific mutations to increased virulence. If the outbreak strain carries any of those mutations, the question of origin becomes immediately more serious.

References

1. Hantavirus cluster linked to cruise ship travel, Multi-country - As of 4 May 2026, seven cases (two laboratory confirmed cases of hantavirus and five suspected cases...

2. Cruise Ship Struck by Hantavirus Is to Head to Canary Islands ... - The MV Hondius left Ushuaia, Argentina, on April 1, making stops in “remote and ecologically diverse...

3. timeline of the medical situation on board the m/v Hondius - Oceanwide Expeditions is still dealing with a serious medical situation on board the m/v Hondius, wh...

4. Hantavirus cruise ship latest: British patient 'no longer in critical ... - Three patients were medically evacuated from the MV Hondius to receive treatment in the Netherlands,...

5. Cruise ship's hantavirus outbreak puts researchers in ... - There have now been six cases of respiratory illness among the ship's passengers, three of whom died...

6. Hantavirus outbreak on cruise ship under investigation - ECDC - Hantavirus infection has been laboratory-confirmed in two individuals in connection with the cluster...

7. Hantavirus strain that spreads between humans found in cruise ship ... - Eight cases of hantavirus - three confirmed and five suspected - have so far been identified in peop...

8. More hantavirus suspected from cruise ship. Latest on illnesses. - Three people have died since the outbreak began on the MV Hondius, a cruise ship run by Netherlands-...

9. Hantavirus cruise ship live updates: Patients evacuated ... - AP News - Three passengers have died and several others have been sickened by hantavirus on board the MV Hondi...

10. Biodefense Implications of New-World Hantaviruses - This review seeks to clarify the categorization of Hantaviruses as a bioweapon, whilst defining the ...

11. Person-to-Person Transmission of Andes Virus in Hantavirus ... - CDC - Andes virus is unique among hantaviruses because it can be transmitted from person to person. This m...

12. Hantavirus Disease – Argentina - World Health Organization (WHO) - Between 28 October 2018 – 20 January of 2019, a total of 29 laboratory-confirmed cases of HPS, inclu...

13. BIOWAR - The National Security Archive - Regarding biological weapons, Nixon agreed that the U.S. would renounce the use of lethal as well as...

14. United States biological weapons program - Wikipedia - Over the course of its 27-year history, the program weaponized and stockpiled seven bio-agents — Bac...

15. Historical Background of the U.S. Biologic-Warfare Program - (The report was declassified in 1988.) The report stated in part: The value of biological warfare wi...

16. 166. Statement Issued by President Nixon, November 25, 1969 - The United States shall renounce the use of lethal biological agents and weapons, and all other meth...

17. How DNA Evidence Confirmed a Soviet Cover-Up of an Anthrax ... - It was an accident at a clandestine biological weapons lab that allowed deadly anthrax spores to con...

18. Sverdlovsk anthrax leak - Adam Smith Institute - An official cover-up pointed to tainted meat as the cause of the fatalities, but all medical records...

19. Anthrax at Sverdlovsk, 1979 - The National Security Archive - This DIA report provides an updated summary of the strong circumstantial evidence indicating that th...

20. Sverdlovsk anthrax leak - Wikipedia - On 2 April 1979, spores of Bacillus anthracis (the causative agent of anthrax) were accidentally rel...

21. Sverdlovsk | Meselson CBW Archive - In April and May 1979, an unusual anthrax epidemic occurred in Sverdlovsk, Union of Soviet Socialist...

22. Biological Weapons Convention (BWC) Compliance Protocol - The 1972 Biological and Toxin Weapons Convention (BWC) bans the development, stockpiling, transfer, ...

23. Putting Teeth in the Biological Weapons Convention - As an alternative to the BWC Protocol, which Bolton bluntly stated was “dead, and is not going to be...

24. US rejects biological weapons convention protocol - PMC - NIH - The convention, banning the use of biological weapons, was ratified by 143 nations but lacked means ...

25. Expression of mouse interleukin-4 by a recombinant ectromelia virus ... - Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte ...

26. Expression of Mouse Interleukin-4 by a Recombinant Ectromelia ... - 2001. Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymph...

27. Killer mousepox virus raises bioterror fears - New Scientist - The researchers added the gene for IL-4 to boost antibody production. The surprise was that it total...

28. Dual Use Biotechnology Research: The Case for Protective Oversight - US scientist Mark Buller later built upon this work, producing a mousepox virus so lethal that it ki...

29. The Deadliest Flu: The Complete Story of the Discovery and ... - A report of this work, “Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus”...

30. Characterization of the Reconstructed 1918 Spanish Influenza ... - In the present study, we generated a virus containing the complete coding sequences of the eight vir...

31. Biosecurity and biosafety in research on emerging pathogens - Dear Editor, Last year, two research teams led by Dr Yoshihiro Kawaoka (University of Wisconsin at M...

32. Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets - Avian flu can acquire the capacity for airborne transmission between mammals without recombination i...

33. Dual Use Research of Concern: Fouchier H5N1 Study Finally ... - Dutch virologist Ron Fouchier has been at the center of the debate on Dual Use Research of Concern (...

34. Fouchier study reveals changes enabling airborne spread of H5N1 - Fouchier's study is one of two H5N1 transmissibility experiments that sparked a fierce controversy b...

35. Experimental adaptation of an influenza H5 HA confers respiratory ... - The transmissible H5 reassortant virus preferentially recognized human-type receptors, replicated ef...

36. First Human Isolate of Hantavirus (Andes virus) in the Americas - PMC - Antibody studies were conducted at biosafety level 2 (BSL-2) facilities, but viral isolation attempt...

37. Temporal Analysis of Andes Virus and Sin Nombre Virus Infections ... - Andes virus (ANDV) and Sin Nombre virus (SNV) are rodent-borne hantaviruses that cause a highly leth...

38. Development of a minigenome system for Andes virus, a New World ... - Here, we describe the first successful minigenome system for a New World hantavirus, as well as many...

39. Andes Virus Genome Mutations That Are Likely Associated ... - PMC - We performed whole-genome sequencing with bait enrichment techniques to analyze Andes virus (ANDV), ...

40. High genomic stability of Andes virus following successive passage ... - Surprisingly, even after 25 passages, minimal mutations occurred in ANDV CHI-7913 genomes, with only...

41. Molecular map reveals Andes hantavirus entry protein at ... - Phys.org - New findings published in the journal Cell about the Andes virus, a hantavirus endemic to the southw...

42. Fact Sheet: The Nunn-Lugar Cooperative Threat Reduction Program - Housed within the Department of Defense's Defense Threat Reduction Agency (DTRA), the CTR Program in...

43. Threat Reduction Program Extends Reach to Ukrainian Biological ... - As a first step toward implementation of the agreement, the Defense Threat Reduction Agency (DTRA) w...

44. [PDF] Biological Threat Reduction Program Activities in Ukraine - Reduction Agency (DTRA). Since 2005, BTRP has partnered with the Government of Ukraine to support pe...

45. 'Hell is coming': Bill Ackman nets $2 billion in bet against market ... - Ackman said the fund completed the exit from his bets against the market on March 23 and generated $...

46. Billionaire Bill Ackman Made 100-Fold Return On Coronavirus ... - Billionaire investor Bill Ackman made $2.6 billion on a $27 million coronavirus hedge. On Monday, he...

47. Short Sellers Made Over $50 Billion During Coronavirus Sell-Off - Short sellers added to their US positions during the recent coronavirus-related sell-off, making mor...

48. The Fed - Business entry and exit in the COVID-19 pandemic - The early pandemic period featured surging establishment closures, many of which were temporary and ...

49. Breaking into new markets: pandemic pivots in 2020 and 2021 - According to research conducted by Simply Business, the pandemic cost small businesses in the UK abo...

50. Impact of COVID Pandemic on eCommerce - This chart shows us clearly the impact to global ecommerce revenues the pandemic has had, adding an ...

51. Pfizer and BioNTech Announce an Agreement with U.S. ... - U.S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to...

52. US public investment in development of mRNA covid-19 vaccines - These grants combined with other identified US government grants and contracts totaled $31.9bn (£26....

53. [PDF] ADVANCED PURCHASE AGREEMENTS FOR COVID-19 VACCINES - Public investment in the vaccine development: Moderna benefited from US government funding of. $ 2.5...

54. Big Pharma raked in USD 90 billion in profits with COVID-19 vaccines - Pfizer, BioNTech, Moderna, and Sinovac made an extraordinary USD 90 billion in profits on their COVI...

55. Did billionaire wealth nearly triple one year during COVID? - CT Mirror - Billionaire wealth grew during the COVID pandemic due in part to a strong stock market and returns o...

56. Ten richest men double their fortunes in pandemic while incomes of ... - Billionaires' wealth has risen more since COVID-19 began than it has in the last 14 years. At $5 tri...

57. How the Coronavirus Helped Grow Amazon's Profits and Power - TIME - Amazon has gained half a trillion dollars in market value just this year, and shares should climb ev...

58. Winners and losers of the COVID‐19 pandemic: An excess profits ... - In this paper, we study the gains and losses incurred during the COVID‐19 pandemic. We distinguish b...

59. Reflections on Naomi Klein's Pandemic Shock Doctrine - The emergence of the Pandemic Shock Doctrine thus urges us to consider digital capitalism not just a...